{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T13:53:40Z","timestamp":1794664420676,"version":"4.9.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T00:00:00Z","timestamp":1772928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"University-Hospital Joint Fund Project of Guangzhou University of Chinese Medicine","award":["GZYZS2024D05"],"award-info":[{"award-number":["GZYZS2024D05"]}]},{"name":"Medical Scientific Research Foundation of Guangdong Province","award":["B2025211"],"award-info":[{"award-number":["B2025211"]}]},{"name":"National Demonstration Pilot Project for the Inheritance and Development of Traditional Chinese Medicine"},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82341232"],"award-info":[{"award-number":["82341232"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Key Research and Development Program of China","award":["2025YFE0107400"],"award-info":[{"award-number":["2025YFE0107400"]}]},{"name":"he Grand Challenges and Future Network of the International Partnership Program of the Chinese Academy of Sciences","award":["083GJHZ2023021GC & 083GJHZ2023012FN"],"award-info":[{"award-number":["083GJHZ2023021GC & 083GJHZ2023012FN"]}]},{"name":"Natural Science Foundation of Shanghai Municipal","award":["24ZR1477500"],"award-info":[{"award-number":["24ZR1477500"]}]},{"name":"CAS President\u2019s International Fellowship Initiative","award":["2024VBB0004"],"award-info":[{"award-number":["2024VBB0004"]}]},{"name":"High-level Innovative Research Institute from Department of Science and Technology of Guangdong Province","award":["2021B0909050003"],"award-info":[{"award-number":["2021B0909050003"]}]},{"DOI":"10.13039\/501100017291","name":"Zhongshan Municipal Bureau of Science and Technology","doi-asserted-by":"crossref","award":["LJ2021001 & CXTD2022011"],"award-info":[{"award-number":["LJ2021001 & CXTD2022011"]}],"id":[{"id":"10.13039\/501100017291","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04265-w","type":"journal-article","created":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T13:45:07Z","timestamp":1772977507000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Microneedle-based delivery of cell membrane vesicles as IL-17RA decoys for Psoriasis treatment"],"prefix":"10.1186","volume":"24","author":[{"given":"Bin","family":"Tu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weifeng","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akmal","family":"Asrorov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ergang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongzhuo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongqiu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weibo","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,8]]},"reference":[{"issue":"8","key":"4265_CR1","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/nri2586","volume":"9","author":"SL Gaffen","year":"2009","unstructured":"Gaffen SL. Structure and signalling in the IL-17 receptor family. Nat Rev Immunol. 2009;9(8):556\u201367.","journal-title":"Nat Rev Immunol"},{"key":"4265_CR2","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1146\/annurev-immunol-101819-092536","volume":"39","author":"S Majumder","year":"2021","unstructured":"Majumder S, McGeachy MJ. IL-17 in the pathogenesis of disease: good intentions gone awry. Annu Rev Immunol. 2021;39:537\u201356.","journal-title":"Annu Rev Immunol"},{"issue":"3","key":"4265_CR3","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s12016-018-8702-3","volume":"55","author":"A Blauvelt","year":"2018","unstructured":"Blauvelt A, Chiricozzi A. The immunologic role of IL-17 in psoriasis and psoriatic arthritis pathogenesis. Clin Rev Allergy Immunol. 2018;55(3):379\u201390.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"4265_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01620-3","volume":"8","author":"L Huangfu","year":"2023","unstructured":"Huangfu L, Li R, Huang Y, Wang S. The IL-17 family in diseases: from bench to bedside. Signal Transduct Target Ther. 2023;8(1):402.","journal-title":"Signal Transduct Target Ther"},{"issue":"14","key":"4265_CR5","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1056\/NEJMoa1503824","volume":"373","author":"M Lebwohl","year":"2015","unstructured":"Lebwohl M, Strober B, Menter A, Gordon K, Weglowska J, Puig L, Papp K, Spelman L, Toth D, Kerdel F, Armstrong AW, Stingl G, Kimball AB, Bachelez H, Wu JJ, Crowley J, Langley RG, Blicharski T, Paul C, Lacour JP, Tyring S, Kircik L, Chimenti S, Callis Duffin K, Bagel J, Koo J, Aras G, Li J, Song W, Milmont CE, Shi Y, Erondu N, Klekotka P, Kotzin B, Nirula A. Phase 3 studies comparing Brodalumab with Ustekinumab in psoriasis. N Engl J Med. 2015;373(14):1318\u201328.","journal-title":"N Engl J Med"},{"issue":"8","key":"4265_CR6","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1016\/j.cell.2025.03.005","volume":"188","author":"B Lee","year":"2025","unstructured":"Lee B, Kwon JT, Jeong Y, Caris H, Oh D, Feng M, et al. Inflammatory and anti-inflammatory cytokines bidirectionally modulate amygdala circuits regulating anxiety. Cell. 2025;188(8):2190-2202.e15.","journal-title":"Cell"},{"issue":"8","key":"4265_CR7","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1016\/j.cell.2025.03.006","volume":"188","author":"Y Lee","year":"2025","unstructured":"Lee Y, Ishikawa T, Lee H, Lee B, Ryu C, Davila Mejia I, et al. Brain-wide mapping of immune receptors uncovers a neuromodulatory role of IL-17E and the receptor IL-17RB. Cell. 2025;188(8):2203-2217.e17.","journal-title":"Cell"},{"issue":"2","key":"4265_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12050","volume":"10","author":"F Cocozza","year":"2020","unstructured":"Cocozza F, N\u00e9vo N, Piovesana E, Lahaye X, Buchrieser J, Schwartz O, et al. Extracellular vesicles containing ACE2 efficiently prevent infection by SARS-CoV-2 Spike protein-containing virus. J Extracell Vesicles. 2020;10(2):1-8.e12050.","journal-title":"J Extracell Vesicles"},{"issue":"8","key":"4265_CR9","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/s41565-021-00923-2","volume":"16","author":"Z Li","year":"2021","unstructured":"Li Z, Wang Z, Dinh PC, Zhu D, Popowski KD, Lutz H, Hu S, Lewis MG, Cook A, Andersen H, Greenhouse J, Pessaint L, Lobo LJ, Cheng K. Cell-mimicking nanodecoys neutralize SARS-CoV-2 and mitigate lung injury in a non-human primate model of COVID-19. Nat Nanotechnol. 2021;16(8):942\u201351.","journal-title":"Nat Nanotechnol"},{"issue":"12","key":"4265_CR10","doi-asserted-by":"publisher","first-page":"5161","DOI":"10.1016\/j.apsb.2024.08.013","volume":"14","author":"C Wu","year":"2024","unstructured":"Wu C, Yu Q, Huang C, Li F, Zhang L, Zhu D. Microneedles as transdermal drug delivery system for enhancing skin disease treatment. Acta Pharm Sin B. 2024;14(12):5161\u201380.","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"4265_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s40820-025-01662-y","volume":"17","author":"Y Han","year":"2025","unstructured":"Han Y, Qin X, Lin W, Wang C, Yin X, Wu J, et al. Microneedle-based approaches for skin disease treatment. Nano-Micro Lett. 2025;17(1):132.","journal-title":"Nano-Micro Lett"},{"key":"4265_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2023.115082","volume":"201","author":"K Glover","year":"2023","unstructured":"Glover K, Mishra D, Gade S, Vora LK, Wu Y, Paredes AJ, et al. Microneedles for advanced ocular drug delivery. Adv Drug Deliv Rev. 2023;201:115082.","journal-title":"Adv Drug Deliv Rev"},{"key":"4265_CR13","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.jconrel.2022.05.045","volume":"348","author":"Z Sartawi","year":"2022","unstructured":"Sartawi Z, Blackshields C, Faisal W. Dissolving microneedles: applications and growing therapeutic potential. J Control Release. 2022;348:186\u2013205.","journal-title":"J Control Release"},{"issue":"4","key":"4265_CR14","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.jaad.2018.11.057","volume":"80","author":"A Menter","year":"2019","unstructured":"Menter A, Strober BE, Kaplan DH, Kivelevitch D, Prater EF, Stoff B, Armstrong AW, Connor C, Cordoro KM, Davis DMR, Elewski BE, Gelfand JM, Gordon KB, Gottlieb AB, Kavanaugh A, Kiselica M, Korman NJ, Kroshinsky D, Lebwohl M, Leonardi CL, Lichten J, Lim HW, Mehta NN, Paller AS, Parra SL, Pathy AL, Rupani RN, Siegel M, Wong EB, Wu JJ, Hariharan V, Elmets CA. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics. J Am Acad Dermatol. 2019;80(4):1029\u201372.","journal-title":"J Am Acad Dermatol"},{"key":"4265_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000478072","volume":"53","author":"SJ Lockwood","year":"2018","unstructured":"Lockwood SJ, Prens LM, Kimball AB. Adverse reactions to biologics in psoriasis. Curr Probl Dermatol. 2018;53:1\u201314.","journal-title":"Curr Probl Dermatol"},{"issue":"1","key":"4265_CR16","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/mt.2012.180","volume":"21","author":"S Ohno","year":"2013","unstructured":"Ohno S, Takanashi M, Sudo K, Ueda S, Ishikawa A, Matsuyama N, Fujita K, Mizutani T, Ohgi T, Ochiya T, Gotoh N, Kuroda M. Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells. Mol Ther. 2013;21(1):185\u201391.","journal-title":"Mol Ther"},{"issue":"3","key":"4265_CR17","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adp9009","volume":"11","author":"Y Guo","year":"2025","unstructured":"Guo Y, Wang H, Liu S, Zhang X, Zhu X, Huang L, et al. Engineered extracellular vesicles with DR5 agonistic scFvs simultaneously target tumor and immunosuppressive stromal cells. Sci Adv. 2025;11(3):eadp9009.","journal-title":"Sci Adv"},{"key":"4265_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2021.118168","volume":"267","author":"I Saha","year":"2021","unstructured":"Saha I, Rai VK. Hyaluronic acid based microneedle array: recent applications in drug delivery and cosmetology. Carbohydr Polym. 2021;267:118168.","journal-title":"Carbohydr Polym"},{"issue":"5","key":"4265_CR19","doi-asserted-by":"publisher","first-page":"7512","DOI":"10.1021\/acsnano.1c10718","volume":"16","author":"Q Li","year":"2022","unstructured":"Li Q, Xu R, Fan H, Xu J, Xu Y, Cao P, Zhang Y, Liang T, Zhang Y, Chen W, Wang Z, Wang L, Chen X. Smart mushroom-inspired imprintable and lightly detachable (MILD) microneedle patterns for effective COVID-19 vaccination and decentralized information storage. ACS Nano. 2022;16(5):7512\u201324.","journal-title":"ACS Nano"},{"issue":"3","key":"4265_CR20","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.jconrel.2013.05.026","volume":"170","author":"JD Kim","year":"2013","unstructured":"Kim JD, Kim M, Yang H, Lee K, Jung H. Droplet-born air blowing: novel dissolving microneedle fabrication. J Control Release. 2013;170(3):430\u20136.","journal-title":"J Control Release"},{"issue":"34","key":"4265_CR21","doi-asserted-by":"publisher","first-page":"47938","DOI":"10.1021\/acsami.5c08843","volume":"17","author":"H Liu","year":"2025","unstructured":"Liu H, Xia W, Meng Y, Xu Q, Xia Z, Muhitdinov B, Liu E, Shen H, Huang Y. Drug repurposing with topical paclitaxel delivery for psoriasis treatment enabled by plant-inspired molecular assembly. ACS Appl Mater Interfaces. 2025;17(34):47938\u201350.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"34","key":"4265_CR22","doi-asserted-by":"publisher","first-page":"40228","DOI":"10.1021\/acsami.3c07582","volume":"15","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Gong S, Liu L, Shen H, Liu E, Pan L, Gao N, Chen R, Huang Y. Cyclodextrin-coordinated liposome-in-gel for transcutaneous quercetin delivery for psoriasis treatment. ACS Appl Mater Interfaces. 2023;15(34):40228\u201340.","journal-title":"ACS Appl Mater Interfaces"},{"key":"4265_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13203167","author":"N Saito-Sasaki","year":"2023","unstructured":"Saito-Sasaki N, Sawada Y. S100 proteins in the pathogenesis of psoriasis and atopic dermatitis. Diagnostics. 2023;13(20):3167-13.","journal-title":"Diagnostics"},{"issue":"10275","key":"4265_CR24","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/S0140-6736(21)00184-7","volume":"397","author":"K Ghoreschi","year":"2021","unstructured":"Ghoreschi K, Balato A, Enerb\u00e4ck C, Sabat R. Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis. Lancet. 2021;397(10275):754\u201366.","journal-title":"Lancet"},{"key":"4265_CR25","first-page":"229","volume":"46","author":"C Wu","year":"2025","unstructured":"Wu C, Yang X, Yang K, Yu Q, Huang C, Li F, Zhang L, Zhu D. Compensatory effect-based oxidative stress management microneedle for psoriasis treatment. Bioact Mater. 2025;46:229\u201341.","journal-title":"Bioact Mater"},{"issue":"4","key":"4265_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05790-4","volume":"14","author":"Y Hu","year":"2023","unstructured":"Hu Y, Lei L, Jiang L, Zeng H, Zhang Y, Fu C, et al. LncRNA UCA1 promotes keratinocyte-driven inflammation via suppressing METTL14 and activating the HIF-1\u03b1\/NF-\u03baB axis in psoriasis. Cell Death Dis. 2023;14(4):279.","journal-title":"Cell Death Dis"},{"key":"4265_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232314904","author":"O Kostareva","year":"2022","unstructured":"Kostareva O, Svoeglazova A, Kolyadenko I, Nikulin A, Evdokimov S, Dzhus U, et al. Two epitope regions revealed in the complex of IL-17A and anti-IL-17A V(H)H domain. Int J Mol Sci.2022;23(23):14904.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"4265_CR28","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.jaci.2017.07.004","volume":"140","author":"JE Hawkes","year":"2017","unstructured":"Hawkes JE, Chan TC, Krueger JG. Psoriasis pathogenesis and the development of novel targeted immune therapies. J Allergy Clin Immunol. 2017;140(3):645\u201353.","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"4265_CR29","doi-asserted-by":"publisher","first-page":"4980","DOI":"10.1021\/acsmaterialslett.4c01164","volume":"6","author":"Z Wang","year":"2024","unstructured":"Wang Z, Liu L, Liu E, Chen R, Huang Y, Li Q. Carrier polymer-free dissolvable microneedles enable superhigh drug payload for percutaneous protein delivery. ACS Mater Lett. 2024;6(11):4980\u20137.","journal-title":"ACS Mater Lett"},{"issue":"4","key":"4265_CR30","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1016\/j.apsb.2025.02.038","volume":"15","author":"H Zhou","year":"2025","unstructured":"Zhou H, Zhang S, Liu X, Feng A, Chen S, Liu W. Microneedle delivery platform integrated with Staphylococcus epidermidis-derived extracellular vesicles-based nanoantibiotics for efficient bacterial infection atopic dermatitis treatment. Acta Pharm Sin B. 2025;15(4):2197\u2013216.","journal-title":"Acta Pharm Sin B"},{"key":"4265_CR31","unstructured":"Daewoong Therapeutics. (2025, August 13). Daewoong Therapeutics Microneedle Patch Achieves Best-in-Class Bioavailability, Proving the Strength of Its Drug-Delivery Platform [Press release]. PR Newswire. https:\/\/www.prnewswire.com\/news-releases\/daewoong-therapeutics-microneedle-patch-achieves-best-in-class-bioavailability-proving-the-strength-of-its-drug-delivery-platform-302528778.html"},{"issue":"1","key":"4265_CR32","doi-asserted-by":"publisher","first-page":"3087","DOI":"10.1080\/10717544.2022.2125600","volume":"29","author":"H Kang","year":"2022","unstructured":"Kang H, Zuo Z, Lin R, Yao M, Han Y, Han J. The most promising microneedle device: present and future of hyaluronic acid microneedle patch. Drug Deliv. 2022;29(1):3087\u2013110.","journal-title":"Drug Deliv"},{"key":"4265_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119127","volume":"578","author":"J Zhu","year":"2020","unstructured":"Zhu J, Tang X, Jia Y, Ho CT, Huang Q. Applications and delivery mechanisms of hyaluronic acid used for topical\/transdermal delivery - a review. Int J Pharm. 2020;578:119127.","journal-title":"Int J Pharm"},{"key":"4265_CR34","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.jconrel.2021.07.002","volume":"336","author":"NG Kotla","year":"2021","unstructured":"Kotla NG, Bonam SR, Rasala S, Wankar J, Bohara RA, Bayry J, Rochev Y, Pandit A. Recent advances and prospects of hyaluronan as a multifunctional therapeutic system. J Control Release. 2021;336:598\u2013620.","journal-title":"J Control Release"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04265-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04265-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04265-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T10:29:39Z","timestamp":1776248979000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04265-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,8]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4265"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04265-w","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,8]]},"assertion":[{"value":"23 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Male Balb\/c mice (specific pathogen-free, SPF) were procured from Zhuhai Besttest Biotechnology Co., Ltd. The animals were housed under controlled environmental conditions, including a constant room temperature of 25\u00a0\u00b0C and an automated light-dark cycle. Sterile food and water were provided ad libitum, with regular cage changes. All experimental procedures were conducted in accordance with the guidelines approved by the Institutional Animal Care and Use Committee (IACUC) of Zhongshan Institute for Drug Discovery. (Animal Ethics: 2025-08-HYZ-06).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agree to be published.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"364"}}